Literature DB >> 3373419

Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination.

M S Roberts1, J D Donaldson, M Rowland.   

Abstract

The residence time distribution of noneliminated solutes in the liver can be represented by a variety of stochastic models. The dispersion model (closed and mixed boundary conditions), gamma distribution, log normal distribution and normal distribution models were used to describe output concentration-time profiles after bolus injections into the liver of labeled erythrocytes and albumin. The dispersion model and log normal distribution model provide the best representation of the data and give similar estimates of relative dispersion and availability for varying hepatocellular enzyme activity. The availability of solutes eliminated from the liver by first-order kinetics is determined by the residence time distribution of the solute in the liver and not on events occurring in the liver when a uniform enzyme distribution is assumed. Both enzyme heterogeneity (axial or transverse) and hepatocyte permeability may affect solute availability. A more complex model accounting for enzyme distribution and the micromixing of solute within the liver is required for solutes undergoing saturable kinetics.

Mesh:

Year:  1988        PMID: 3373419     DOI: 10.1007/bf01061862

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  35 in total

1.  THEORY OF THE USE OF ARTERIOVENOUS CONCENTRATION DIFFERENCES FOR MEASURING METABOLISM IN STEADY AND NON-STEADY STATES.

Authors:  K L Zierler
Journal:  J Clin Invest       Date:  1961-12       Impact factor: 14.808

2.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

3.  A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.

Authors:  M S Roberts; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

4.  Convection-dispersion modeling of hepatic elimination.

Authors:  L Bass
Journal:  J Pharm Sci       Date:  1986-03       Impact factor: 3.534

5.  Tracer dilution curves in cardiology and random walk and lognormal distributions.

Authors:  M E Wise
Journal:  Acta Physiol Pharmacol Neerl       Date:  1966

6.  Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.

Authors:  A B Ahmad; P N Bennett; M Rowland
Journal:  J Pharm Pharmacol       Date:  1983-04       Impact factor: 3.765

7.  Albumin binding and hepatic uptake: the importance of model selection.

Authors:  E L Forker; B A Luxon
Journal:  J Pharm Sci       Date:  1983-10       Impact factor: 3.534

Review 8.  Functional implications of liver cell heterogeneity.

Authors:  J J Gumucio; D L Miller
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

9.  Flow dependence of first-order uptake of substances by heterogeneous perfused organs.

Authors:  L Bass
Journal:  J Theor Biol       Date:  1980-09-21       Impact factor: 2.691

10.  Vasomotor control of capillary transit time heterogeneity in the canine coronary circulation.

Authors:  C P Rose; C A Goresky
Journal:  Circ Res       Date:  1976-10       Impact factor: 17.367

View more
  34 in total

1.  An isolated in-situ rat head perfusion model for pharmacokinetic studies.

Authors:  K A Foster; G D Mellick; M Weiss; M S Roberts
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

2.  Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.

Authors:  M S Roberts; Y G Anissimov
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

3.  Analysis of nonlinear and nonsteady state hepatic extraction with the dispersion model using the finite difference method.

Authors:  A Hisaka; Y Sugiyama
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

4.  Quantitative evaluation of capacity-limited hepatobiliary transport based on hepatocellular diffusion model by MULTI(FEM).

Authors:  M Higashimori; K Yamaoka; S Fujitani; T Nakagawa
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-10       Impact factor: 2.745

5.  A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.

Authors:  Yuri G Anissimov; Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-04       Impact factor: 2.745

6.  Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate.

Authors:  M S Roberts; S Fraser; A Wagner; L McLeod
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

7.  Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.

Authors:  Peng Li; Thomas A Robertson; Qian Zhang; Linda M Fletcher; Darrell H G Crawford; Michael Weiss; Michael S Roberts
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

8.  Availability predictions by hepatic elimination models for Michaelis-Menten kinetics.

Authors:  M S Roberts; J D Donaldson; D Jackett
Journal:  J Pharmacokinet Biopharm       Date:  1989-12

9.  A comparative investigation of hepatic clearance models: predictions of metabolite formation and elimination.

Authors:  M V St-Pierre; P I Lee; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1992-04

10.  Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs.

Authors:  L P Rivory; M S Roberts; S M Pond
Journal:  J Pharmacokinet Biopharm       Date:  1992-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.